Soligenix, Inc. - Common Stock (NQ:SNGX)

0.3590 -0.0064 (-1.75%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Soligenix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Taps IBN to Lead Corporate Communications Strategy

March 25, 2025

Via Investor Brand Network

InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial Results

March 21, 2025

Via Investor Brand Network

Study Shows Bioengineered Materials Can Treat Oral Mucositis

March 20, 2025

Via Investor Brand Network

BioMedNewsBreaks — Why Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’

March 18, 2025

Via Investor Brand Network

Soligenix Announces Participation at the Spartan Capital Investor Conference

October 29, 2024

Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement

Via TheNewswire.com

Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’

March 13, 2025

Via Investor Brand Network

Soligenix Aims To Push The Boundaries In Treating Rare Diseases

February 25, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Soligenix Aims To Push The Boundaries In Treating Rare Diseases

February 25, 2025

Via TheNewswire.com

Improving Patient Quality Of Life: Soligenix Progresses Treatment For Painful Ulcers Associated With Rare Behcet's Disease

February 21, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Improving Patient Quality Of Life: Soligenix Progresses Treatment For Painful Ulcers Associated With Rare Behcet's Disease

February 21, 2025

By Kyle Anthony, Benzinga

Via TheNewswire.com

Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026

February 21, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026

February 21, 2025

By Kyle Anthony, Benzinga

Via TheNewswire.com

Soligenix Targets Psoriasis With New Therapy

January 17, 2025

Soligenix Targets Psoriasis With New Therapy

Via News Direct

EXCLUSIVE: Soligenix's Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year ↗

January 14, 2025

Soligenix's IIS study on HyBryte for cutaneous T-cell lymphoma shows 70% success and strong safety profile, with Phase 3 enrollment ongoing.

Via Benzinga

Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL

December 17, 2024

Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL

Via News Direct

EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer ↗

December 16, 2024

Soligenix opens enrollment for the Phase 3 FLASH2 study of HyBryte in early-stage CTCL, aiming to confirm extended treatment efficacy over 18 weeks.

Via Benzinga

Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs

November 27, 2024

Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs

Via News Direct

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

November 27, 2024

Via ACCESSWIRE

Soligenix to Present at November 21st Virtual Investor Summit Microcap Event

November 15, 2024

Via ACCESSWIRE

Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels ↗

November 14, 2024

Soligenix starts Phase 2 trial of SGX945 for Behçet's Disease, aiming to enroll 25 patients and report results by mid-2025. Trial includes efficacy assessments.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 01, 2024

Via Benzinga

Soligenix Announces Participation at the Spartan Capital Investor Conference

October 29, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 03, 2024

Via Benzinga

Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket ↗

October 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 02, 2024

Via Benzinga

Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

September 20, 2024

Via ACCESSWIRE

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

August 16, 2024

Via ACCESSWIRE

7 Top Stocks Under $10: July 2024 Edition ↗

July 31, 2024

There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.